Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-Delta5NP3
US11357846B2 · kind B2 · utility
2Cited by
10References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2021 |
| Grant date | Jun 14, 2022 |
| Priority date | — |
| Expiry date | Aug 20, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.